当前位置:首页 - 行情中心 - 新华制药(000756) - 财务分析 - 现金流量表

新华制药

(000756)

  

流通市值:80.00亿  总市值:112.02亿
流通股本:4.93亿   总股本:6.90亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,806,443,339.791,781,364,260.927,941,398,602.275,817,209,879.99
  收到的税费返还34,313,637.8318,190,948.95155,876,316.01137,300,816.13
  收到其他与经营活动有关的现金36,470,462.7135,770,336.6293,054,265.5751,109,225.29
  经营活动现金流入小计3,877,227,440.331,835,325,546.498,190,329,183.856,005,619,921.41
  购买商品、接受劳务支付的现金2,782,539,243.671,351,404,814.185,601,050,514.464,208,317,081.25
  支付给职工以及为职工支付的现金534,879,287.39271,516,877.181,058,575,737.05793,995,883.11
  支付的各项税费105,157,989.9254,142,412.23252,081,164.63193,564,964.43
  支付其他与经营活动有关的现金220,518,566.62149,836,252.8911,011,318.76555,501,333.22
  经营活动现金流出小计3,643,095,087.61,826,900,356.397,822,718,734.95,751,379,262.01
  经营活动产生的现金流量净额234,132,352.738,425,190.1367,610,448.95254,240,659.4
二、投资活动产生的现金流量:
  取得投资收益收到的现金3,115,076.81,495,894.48,182,2008,182,200
  处置固定资产、无形资产和其他长期资产收回的现金净额439,943.8961,943.89654,705729,528
  收到的其他与投资活动有关的现金13,4408,603,760--
  投资活动现金流入小计3,568,460.6910,161,598.298,836,9058,911,728
  购建固定资产、无形资产和其他长期资产支付的现金76,807,920.6849,094,672.29212,421,547.59149,687,297.51
  支付其他与投资活动有关的现金3,000,00011,603,7608,626,080-
  投资活动现金流出小计79,807,920.6860,698,432.29221,047,627.59149,687,297.51
  投资活动产生的现金流量净额-76,239,459.99-50,536,834-212,210,722.59-140,775,569.51
三、筹资活动产生的现金流量:
  吸收投资收到的现金55,577,524.555,577,524.563,259,085.558,785,728
  取得借款收到的现金459,800,000134,800,000860,307,702.93898,807,702.93
  收到其他与筹资活动有关的现金2,000,0001,000,00055,611,732.351,500,000
  筹资活动现金流入小计517,377,524.5191,377,524.5979,178,520.78959,093,430.93
  偿还债务支付的现金622,977,569.79106,524,677.21552,058,243.97598,691,243.97
  分配股利、利润或偿付利息支付的现金30,301,466.88767,197.22240,352,752.05224,284,520.62
  其中:子公司支付给少数股东的股利、利润8,982,000-14,505,663.439,980,000
  支付其他与筹资活动有关的现金814,747.45290,144.511,988,950.58966,101.32
  筹资活动现金流出小计654,093,784.12107,582,018.94794,399,946.6823,941,865.91
  筹资活动产生的现金流量净额-136,716,259.6283,795,505.56184,778,574.18135,151,565.02
四、汇率变动对现金及现金等价物的影响5,778,620.843,506,892.9515,012,454.6512,684,524.21
五、现金及现金等价物净增加额26,955,253.9645,190,754.61355,190,755.19261,301,179.12
  加:期初现金及现金等价物余额1,136,875,010.061,136,875,010.06781,684,254.87781,684,254.87
  期末现金及现金等价物余额1,163,830,264.021,182,065,764.671,136,875,010.061,042,985,433.99
补充资料:
  净利润231,168,471.79-486,714,573.88-
  资产减值准备50,287,533.79-51,613,568.72-
  固定资产和投资性房地产折旧250,047,274.54-488,620,589.31-
  无形资产摊销31,067,568.57-50,223,901.76-
  长期待摊费用摊销2,348,380.85-4,726,630.46-
  处置固定资产、无形资产和其他长期资产的损失-1,711,209.17--1,419,533.61-
  固定资产报废损失236,486.07-5,045,910.64-
  财务费用15,670,470.77-24,726,825.12-
  投资损失-5,879,082.58--9,836,416.05-
  递延所得税5,365,550.9-14,752,093.29-
  其中:递延所得税资产减少6,856,749.64--1,442,340.18-
    递延所得税负债增加-1,491,198.74-16,194,433.47-
  存货的减少-6,560,276.59--11,431,347.68-
  经营性应收项目的减少-427,595,333.26--629,942,578.49-
  经营性应付项目的增加72,201,697.84--153,629,238.13-
  其他7,568,060.46-35,882,504-
  现金的期末余额1,163,830,264.02-1,136,875,010.06-
  减:现金的期初余额1,136,875,010.06-781,684,254.87-
  现金及现金等价物的净增加额26,955,253.96-355,190,755.19-
公告日期2025-08-272025-04-292025-03-312024-10-30
审计意见(境内)标准无保留意见
TOP↑